Table 7.
Sensitivity analyses for prescription of ULT and for ULT adherence >80 %, additionally adjusting for patient preference for pharmacological vs. non-pharmacological treatments
| Patient characteristics | ULT prescribeda | Urate-lowering medication adherence >80 %b |
|---|---|---|
| Gender | P = 0.58 | P = 0.12 |
| Male | 0.90 (0.58, 1.38) | 2.10 (0.81, 5.44) |
| Female | Ref | Ref |
| Age groups | P = 0.98 | P = 0.91 |
| 21–40 years | 0.82 (0.24, 2.82) | 0.89 (0.08, 10.2) |
| 41–60 years | 0.88 (0.28, 2.71) | 1.00 (0.11, 9.31) |
| 61–80 years | 0.92 (0.29, 2.91) | 1.27 (0.13, 12.00) |
| >80 years | Ref | Ref |
| Race | P = 0.99 | P = 0.64 |
| African American | 1.01 (0.50, 2.04) | 0.25 (0.03, 1.97) |
| Hispanic or Latino | 1.37 (0.46, 4.05) | 0.85 (0.09, 7.83) |
| Asian | 1.12 (0.59, 2.12) | 1.96 (0.72, 5.31) |
| American Indian or Alaskan native | ----- | --- |
| Hawaiian or Pacific Islander | 1.84 (0.40, 8.42) | 1.96 (0.17, 23.00) |
| Other | 0.90 (0.58, 2.78) | 1.61 (0.29, 8.86) |
| White/Caucasian | Ref | Ref |
| Choice of preferred therapy for gout | ||
| Non-ULT | 1.00 (0.69, 1.46)** | 1.02 (0.51, 2.04)*** |
| ULT | Ref | Ref |
**p-value =1.00; ***p-value =0.96
---, no odds ratio calculable since no patients in this category
aReference category is ULT was not prescribed
bReference category is urate-lowering medication adherence of ≤80 % in the last month